Bachem and Jitsubo CO., LTD. recently announced the signature of an exclusive Licensing Agreement for Jitsubo’s Molecular Hiving™ technology. Under the License agreement, Jitsubo will develop selected manufacturing processes using their Molecular Hiving technology and transfer these processes to Bachem. Bachem will further optimize, scale up and produce for commercial applications.
Molecular Hiving is a tag-assisted liquid-phase peptide synthesis technology developed by Professor Kazuhiro Chiba at Tokyo University of Agriculture and Technology. This technology uses a hydrophobic tag, which is applied in the same way as the resin for solid-phase peptide synthesis (SPPS) processes.
The same standard Fmoc amino acid derivatives as for SPPS are applied for assembling the peptide chain. However, all couplings and cleavages of the Fmoc protecting group are performed in solution allowing for fast reactions and direct in-process controls, e.g. by HPLC. Excess reagents as well as coupling and cleavage related by-products are solely removed by aqueous extractions. Therefore, intermediate isolation of the tag-bound peptide and excessive washing steps are not required for Molecular Hiving™ technology.
In this webinar, the speaker will guide attendees through the individual steps for synthesis of peptides applying Molecular Hiving™ technology. Webinar attendees will learn about the scalability and the substantial advantages of this technology regarding efficiency and towards greener manufacturing, as solvent consumption and material requirements are significantly reduced compared to conventional SPPS processes. Molecular Hiving™ also allows the synthesis of peptides without the use of solvents and reagents which are carcinogenic, mutagenic, or toxic to reproduction (CMR substances). This makes peptide products manufactured by this technology highly attractive for the pharmaceutical and cosmetics industry.
Dr. Wolfgang Seufert, Director Production III – Process Development, Bachem
Dr. Wolfgang Seufert is leading a process development team within the Production department at Bachem AG. Having joined Bachem more than 12 years ago and working in several positions at the Bubendorf and Torrance sites of Bachem, he has gained broad experience in development, scale up and manufacturing of peptides, both LPPS and SPPS. Dr. Seufert studied chemistry at the universities of Giessen and Leipzig and received his PhD from the University of Basel for his work on cyclization reactions of modified amino acids and peptides.Message Presenter
Who Should Attend?
Scientists in Pharma, Biotech, Cosmetics industries and Universities including:
- Research Scientists and Associates
- PostDocs and PhDs
- Scientific Advisors
- Directors of Research and Development
Other Professionals in the Life Sciences including:
- Product Managers
- Marketing Managers
What You Will Learn
In this webinar, attendees will learn about:
- How to synthesize peptides by Molecular Hiving™ technology
- Learn of the advantages and the environmental benefits of Molecular Hiving™ technology
- Manufacture of peptides without CMR solvents and reagents
- Bachem’s partnership with Jitsubo
The Swiss based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of pepTides and oligonucleoTides. As a full service provider Bachem offers products for clinical development and commercial applications as well as a comprehensive catalog and exclusive custom synthesis. With 50 years of experience and subsidiaries in Switzerland, the United States, the United Kingdom and Japan, Bachem is the partner of choice for the biotech and pharma industry worldwide.